Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2000
03/29/2000CN1248466A Yuchuang oinment for treating sore
03/29/2000CN1248464A Medicine for anti-tubercle bacillus and preparation process thereof
03/29/2000CN1248461A Health care oral liquid for old people and preparation process thereof
03/29/2000CN1248460A Medicine for treating burn (scald) and preparation process
03/29/2000CN1248449A Traditional Chinese medicinal preparation for treating cancer
03/29/2000CN1248448A Scorption and ant health care liquor
03/29/2000CN1248444A Traditional Chinese medicinal preparation for treating pulmonary tuberculosis
03/29/2000CN1248443A Quick-acting traditional Chinese medicinal preparation for fracture setting
03/29/2000CN1248442A Marine organism extract with anticancer function
03/29/2000CN1050759C Medicinal composition for curing hysteromyoma and preparation process
03/29/2000CN1050757C Traditional Chinese medicine for stimulating the blood circulation and causing the muscles and joints to relax
03/29/2000CN1050756C Medicine for curing cranial vascular and cardiovascular disease and preparation process thereof
03/29/2000CN1050755C Traditional Chinese medicine for treating bleeding disease and preparation process thereof
03/28/2000US6043215 Preparation of factor IX
03/28/2000US6042839 Containing water soluble carboxylated gum and clay crosslinked with metal ions; for cosmetic and/or pharmaceutical products
03/28/2000US6042830 Viral agent associated with mystery swine disease
03/26/2000CA2403011A1 Apparatus for electrical moxibustion using the extract
03/26/2000CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract
03/23/2000WO2000015821A1 Recombinant adenovirus for tissue specific expression in heart
03/23/2000WO2000015820A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015788A2 Dna sequence encoding oncofetal ferritin protein
03/23/2000WO2000015780A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
03/23/2000WO2000015767A2 Antigen-presenting cells and their use in therapy
03/23/2000WO2000015765A1 Enhanced submucosal tissue graft constructs
03/23/2000WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
03/23/2000WO2000015264A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015175A2 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells
03/23/2000WO2000002520A3 T-lymphocyte exchange
03/23/2000WO2000000597A3 Non-symbiotic plant hemoglobins to maintain cell energy status
03/23/2000WO1999061085A3 Method and compositions for treatment of cancers
03/23/2000WO1999056773A9 Composition comprising tumor cells and extracts and method of using thereof
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000DE19838377A1 Verfahren und Vorrichtung zur Extraktherstellung aus biologischem Material, dadurch hergestellte Extrakte und deren Verwendung Method and apparatus for manufacture of extracts from biological material, characterized Extracts prepared and their use
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343355A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000CA2343354A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
03/23/2000CA2342589A1 Enhanced submucosal tissue graft constructs
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/22/2000EP0987325A1 Method for separating cells
03/22/2000EP0986636A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
03/22/2000EP0986394A1 Anti-coagulation of blood, blood plasma or synovial fluid products
03/22/2000EP0986314A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
03/22/2000EP0986302A1 A method of treating cancer
03/22/2000EP0794193B1 Substance mk7634, process for production thereof, and anthelminthic containing said substance
03/22/2000CN1248290A Method for induction of apoptotic cell death in malignant cells, through reduction of the RB to apoptosis inducing proteins ratio
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1248245A Frangible compounds for pathogen inactivation
03/22/2000CN1248178A Method and device for production of small organic compounds from blood products
03/22/2000CN1248171A Method for purifying blood plasma and apparatus suitable therefor
03/22/2000CN1247761A Rheumatism treating medicine
03/22/2000CN1247760A Heart disease treating medicine
03/22/2000CN1247759A Hemiplegia treating pill
03/22/2000CN1247757A Cancer treating medicine capsule
03/22/2000CN1247755A Hepatitis treating medicine and its production process
03/22/2000CN1247750A Medicine for neurasthenia and its preparation
03/22/2000CN1247749A Medicine liquid capable of activating blood circulation to dissipate blood stasis, nourishing Yin, protecting Yang and treating soft tissue injury
03/22/2000CN1247746A Osteomyelitis treating medicine and method
03/22/2000CN1050519C Chinese medicine granule for treatment of acne
03/22/2000CN1050518C Kidney-warming and Yang-strengthening and its preparing method
03/22/2000CN1050516C Intestines and stomach health-care tincture
03/22/2000CN1050515C Chinese herbs composition for treatment of leukaemia and prepn. thereof
03/21/2000US6040441 Isolated recombinant cdna which encodes a protein having one or more cysteine containing domains; for diagnosis and therapy
03/21/2000US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections
03/21/2000US6040180 Culturing of central nervous system stem cells in serum-free culture medium containing a growth factor, replacing with serum-free/growth factor-free medium, harvesting stem cells, plating, and culturing in serum-free/glutamic acid-free media
03/21/2000US6040177 Adding large number of non-dividing peripheral blood mononuclear cells as feeder cells to t-cells in culture medium, activating t-cell receptor complex, adding vector and incubating producing antigen-specific and restricted cells
03/21/2000US6040174 Defective adenoviruses and corresponding complementation lines
03/21/2000US6040170 Human cytomegalovirus DNA sequences
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6039760 Composite living skin equivalent
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014244A2 Treatment of cervical cancer
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000WO2000013693A2 Antipollution plant complex, production process and utilization of said complex in the preparation of pharmaceutical and/or cosmetic compositions
03/16/2000WO2000013677A1 Nanogel networks and biological agent composition thereof
03/16/2000WO2000006704A3 Hematopoietic cell composition for use in transplantation
03/16/2000WO2000000628B1 Replication-defective recombinant adenovirus with mutated major late promoter
03/16/2000WO2000000216A3 Use of poxviruses as enhancer of specific immunity
03/16/2000WO2000000209A3 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
03/16/2000WO1999067363A9 Ependymal neural stem cells and method for their isolation
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999050403A9 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
03/16/2000CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000CA2342800A1 Nanogel networks and biological agent composition thereof
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/15/2000EP0985416A2 Process and device for making an extract of biological material
03/15/2000EP0985047A2 Somatic gene therapy to suppress secondary cataract formation
03/15/2000EP0985046A1 A soluble vaccinia virus protein that binds chemokines
03/15/2000EP0985028A2 Transplants for myocardial scars and method and cellular preparations therefor
03/15/2000EP0984790A1 Herpes simplex virus vp22 vaccines and methods of use
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0653939B1 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247086A Process for making medical wine for treating rheumatism
03/15/2000CN1247084A Chinese medicine for treating diseases caused by fatigue
03/15/2000CN1247077A Medical oil for treating burn and scald and its preparing process
1 ... 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 ... 1259